Roche Gets EC Nod for Follicular lymphoma Maintenance Therapy - Genetic Engineering News
Genetic Engineering NewsRoche Gets EC Nod for Follicular lymphoma Maintenance TherapyGenetic Engineering NewsThe Prima study has also been used as the basis of a rituximab sBLA filing to FDA for the same follicular lymphoma indication, which Genentech submitted in ...Rituximab Approved in the EU for Maintenance Treatment of Follicular lymphomaDG NewsRoche's Mabthera Wins EU Approval For Blood Cancer TypeWall Street JournalEurope backs broader use of Roche's MabTheraReutersInPharmall 15 news articles��
Blog Content
Post a Comment